Castle Biosciences CSTL Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's change in lease liabilities?
- Castle Biosciences (CSTL) reported change in lease liabilities of -$172K in Q1 2026.
- How has Castle Biosciences's change in lease liabilities changed year-over-year?
- Castle Biosciences's change in lease liabilities increased by 67.3% year-over-year, from -$526K to -$172K.
- What is the long-term trend for Castle Biosciences's change in lease liabilities?
- Over 3 years (2021 to 2025), Castle Biosciences's change in lease liabilities has grown at a 14.4% compound annual growth rate (CAGR), from -$852K to -$1.28M.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.